Position history for BlackRock, Inc.'s holdings in TAYSHA GENE THERAPIES INC
BlackRock, Inc. holds 18.6M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $102.5M as of 2025-Q4. The position was increased (++13.9% shares). TSHA represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$102.5M
Current Shares
18.6M
Total Value Change
+$79.1M
Total Shares Change
+5.1M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, MORGAN STANLEY, RTW INVESTMENTS, LP
Increased |
| 18.6M |
+13.9% |
| $102.5M |
| 0.0% |
| $5.66 |
34 |
| 2025-Q3 | Increased | 16.4M | +23.0% | $53.5M | 0.0% | $3.16 | 36 |
| 2025-Q2 | Decreased | 13.3M | -2.1% | $30.7M | 0.0% | $2.38 | 0 |
| 2025-Q1 | Increased | 13.6M | +0.4% | $18.9M | 0.0% | $1.93 | 28 |
| 2024-Q4 | New | 13.5M | - | $23.4M | 0.0% | $1.73 | 40 |